Mannkind Corp
MNKDNasdaqCIK 899460HealthcareFiscal year ends Dec 31
Reports and events: 343 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-08-2116:10 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-361105 |
| 2026-08-0516:07 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001193125-26-335054 |
| 2026-08-0516:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-335016 |
| 2026-07-2416:01 ET | 8-K | 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-316041 |
| 2026-06-0208:00 ET | 8-K | 8.01 Other events | 0001193125-26-252544 |
| 2026-05-2808:37 ET | 8-K | 8.01 Other events | 0001193125-26-243074 |
| 2026-05-2217:17 ET | 8-K | 5.07 Shareholder vote results | 0001193125-26-237183 |
| 2026-05-0616:05 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001193125-26-208916 |
| 2026-05-0616:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-208910 |
| 2026-04-0716:30 ET | DEF 14A | Proxy statementPeriod 2026-04-07 | 0001193125-26-145613 |
| 2026-02-2608:06 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001193125-26-073516 |
| 2026-02-2608:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-073509 |
| 2025-12-1516:02 ET | 8-K/A | 9.01 Financial statements and exhibits | 0001193125-25-319170 |
| 2025-11-1008:05 ET | 8-K | 8.01 Other events | 0001193125-25-273321 |
| 2025-11-0508:06 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001193125-25-265813 |
| 2025-11-0508:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-265810 |
| 2025-10-0917:17 ET | 8-K | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-25-236064 |
| 2025-08-2708:08 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0000950170-25-111586 |
| 2025-08-2507:33 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-186994 |
| 2025-08-0607:15 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0000950170-25-103535 |
| 2025-08-0607:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-103532 |
| 2025-05-1917:02 ET | 8-K | 5.07 Shareholder vote results | 0000950170-25-074523 |
| 2025-05-1516:08 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-25-120797 |
| 2025-05-0808:10 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0000950170-25-066429 |
| 2025-05-0808:08 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-066426 |
| 2025-04-0117:00 ET | DEF 14A | Proxy statementPeriod 2025-05-14 | 0000950170-25-048683 |
| 2025-02-2616:10 ET | 10-K | Annual reportPeriod 2024-12-31 | 0000950170-25-027735 |
| 2025-02-2616:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-027721 |
| 2025-01-0617:09 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000950170-25-002291 |
| 2024-12-1807:00 ET | 8-K | 3.02 Unregistered sale of equity; 8.01 Other events | 0001193125-24-280821 |
| 2024-11-0716:06 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0000950170-24-123296 |
| 2024-11-0716:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-123273 |
| 2024-08-1408:03 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-24-200252 |
| 2024-08-0708:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-092289 |
| 2024-08-0708:05 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0000950170-24-092288 |
| 2024-05-1617:00 ET | 8-K | 5.07 Shareholder vote results | 0000950170-24-061164 |
| 2024-05-0816:11 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0000950170-24-055661 |
| 2024-05-0816:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-055622 |
| 2024-04-0506:06 ET | DEF 14A | Proxy statementPeriod 2024-05-15 | 0000950170-24-042052 |
| 2024-04-0316:55 ET | 8-K | 8.01 Other events | 0000950170-24-041225 |
| 2024-03-2616:12 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-24-077611 |
| 2024-02-2717:23 ET | 10-K | Annual reportPeriod 2023-12-31 | 0000950170-24-021423 |
| 2024-02-2716:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-021095 |
| 2024-01-0206:06 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-24-000161 |
| 2023-12-2716:15 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-23-303995 |
| 2023-11-0716:11 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0000950170-23-060253 |
| 2023-11-0716:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-060230 |
| 2023-08-0716:12 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0000950170-23-039074 |
| 2023-08-0716:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-039048 |
| 2023-07-0318:00 ET | 8-K | 8.01 Other events | 0000950170-23-031202 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:00 ET. Listed shows no prices and gives no investment advice.